Oncology, cancer prevention, tumor biology, and immunotherapy relevant to longevity
316 articles
New non-invasive urine protein test accurately predicts which biliary tract cancer patients will respond to immunotherapy treatment.
Scientists discover two new histone modifications that create a self-reinforcing cycle promoting breast cancer progression.
New patient-centered outcome measure tracks meaningful recovery time at home after spinal metastases treatment.
New research reveals how tumors sabotage T cell metabolism by transferring dysfunctional mitochondria, offering fresh immunotherapy targets.
![Environmental Toxin Benzo[a]pyrene Linked to Ovarian Cancer Through Gut Microbiome](/_next/image?url=https%3A%2F%2Fd18eact5vmeulb.cloudfront.net%2Fthumbnails%2Fenvironmental-toxin-benzoapyrene-linked-to-ovarian-cancer-through-gut-microbiome.jpg%3Fv%3D1775197834184&w=3840&q=75)
Multi-omics study reveals how the carcinogen benzo[a]pyrene may trigger ovarian cancer via gut bacteria and molecular pathways.
Comprehensive genetic analysis of early-stage lung adenocarcinoma identifies molecular subtypes that predict patient outcomes better than current methods.
Sequential CDK4/6 inhibitor treatment before anti-PD-1 therapy enhances immune response and tumor control in head and neck cancer models.
Flaxseed compounds enhance PD-1 inhibitor effectiveness against breast cancer through gut bacteria modulation and immune system activation.
New technique uses cerebrospinal fluid to decode methylation signatures in children's brain tumors, potentially improving diagnosis.
New research reveals how selenium deficiency drives liver cancer progression through neutrophil aging and immune suppression.
New targeted therapy receives accelerated approval for specific non-small cell lung cancer subtype with HER2 mutations.
New research reveals how cancer radiation treatment causes muscle weakness through a previously unknown tumor-muscle communication pathway.
